Consistently, miR-122-5p has been implicated in promoting hepatic inflammation and oxidative stress through inhibition of FOXO3, thereby contributing to NAFLD progression [65]. This evidence concerns the gene FOXO3 and metabolic dysfunction-associated steatotic liver disease.